PhoPQ regulates acidic glycerophospholipid content of the Salmonella Typhimurium outer membrane.
Gram-negative bacteria have two lipid membranes separated by a periplasmic space containing peptidoglycan. The surface bilayer, or outer membrane (OM), provides a barrier to toxic molecules, including host cationic antimicrobial peptides (CAMPs). The OM comprises an outer leaflet of lipid A, the bioactive component of lipopolysaccharide (LPS), and an inner leaflet of glycerophospholipids (GPLs). The structure of lipid A is environmentally regulated in a manner that can promote bacterial infection by increasing bacterial resistance to CAMP and reducing LPS recognition by the innate immune system. The gastrointestinal pathogen, Salmonella Typhimurium, responds to acidic pH and CAMP through the PhoPQ two-component regulatory system, which stimulates lipid A remodeling, CAMP resistance, and intracellular survival within acidified phagosomes. Work here demonstrates that, in addition to regulating lipid A structure, the S. Typhimurium PhoPQ virulence regulators also regulate acidic GPL by increasing the levels of cardiolipins and palmitoylated acylphosphatidylglycerols within the OM. Triacylated palmitoyl-PG species were diminished in strains deleted for the PhoPQ-regulated OM lipid A palmitoyltransferase enzyme, PagP. Purified PagP transferred palmitate to PG consistent with PagP acylation of both lipid A and PG within the OM. Therefore, PhoPQ coordinately regulates OM acidic GPL with lipid A structure, suggesting that GPLs cooperate with lipid A to form an OM barrier critical for CAMP resistance and intracellular survival of S. Typhimurium.
Departments of Microbiology, Medicinal Chemistry, Genome Sciences, Immunology, and Medicine, University of Washington, Seattle, WA 98195.
Zachary D
ZD
Dalebroux
Susana
S
Matamouros
Dale
D
Whittington
Russell E
RE
Bishop
Samuel I
SI
Miller
D000483:Alleles; D023181:Antimicrobial Cationic Peptides / Q000494:pharmacology; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism*; D002308:Cardiolipins / Q000737:chemistry / Q000378:metabolism; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism*; D024881:Drug Resistance, Bacterial / Q000187:drug effects / Q000235:genetics; D015964:Gene Expression Regulation, Bacterial / Q000187:drug effects; D020404:Glycerophospholipids / Q000737:chemistry / Q000378:metabolism*; D010168:Palmitates / Q000378:metabolism; D011112:Polymyxin B / Q000494:pharmacology; D012486:Salmonella typhimurium / Q000166:cytology* / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D014158:Transcription, Genetic / Q000187:drug effects
D023181:Antimicrobial Cationic Peptides; D001426:Bacterial Proteins; D002308:Cardiolipins; D020404:Glycerophospholipids; D010168:Palmitates; C079792:PhoQ protein, Bacteria; C061064:PhoP protein, Bacteria; D011112:Polymyxin B
acyltransferase; lipid remodeling; pathogenesis; signal transduction